Mazindol

This classification denotes a cns stimulant with the molecular formula C16H13ClN2O, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier (SRS UNII) C56709M5NH, chemically known as 5-(p-chlorophenyl)-2,5-dihydro-3h-imidazo(2,1-a)isoindol-5-ol but more generally known as mazindol, which bears US NIH Compound Identifier 4020. European Medicines Agency schedules Mazindol in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB08656MIG. The term MAZINDOL is an International Non-Proprietary Name or INN (see World Health Organization INN reference publication, Volume 29, No. 10 1975, List 15). World Health Organization schedules mazindol in its Anatomical Therapeutic Chemical (ATC) Classification. MAZINDOL is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix. Most nations, for tariff and trade purposes, schedule mazindol under HS 29339190 and SITC 51577. As of Q4 2014, MAZINDOL remains US FDA's Preferred Term for this commodity. Mazindol bears US NLM identifiers UMLS ID C0024977 and NCI Concept Code C66057. SMILES: CLC1CCC(C2(O)N3C(=NCC3)C3C2CCCC3)CC1.